Is Anti-Müllerian Hormone Associated With Fecundability? Findings From the EAGeR Trial

Zarek SM, Shvetha M. Zarek, Mitchell EM, Emily M. Mitchell, Lindsey A. Sjaarda, Sunni L. Mumford, Robert M. Silver, Silver RM, Joseph B. Stanford, Galai N, Noya Galai, Mark V. White, White MV, Karen C. Schliep, Schliep KC, Alan H. DeCherney, DeCherney AH, Enrique F. Schisterman
The Journal of clinical endocrinology and metabolism · 2015 · vol. 100(11) , pp. 4215–21 · doi:10.1210/jc.2015-2474 · PMID:26406293 · PMC4702454
RCT OA: closed
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-08-03 ⓘ

This prospective cohort study found that low or high anti-Müllerian hormone levels were not associated with fecundability in women with a history of pregnancy loss attempting unassisted conception.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: The objective of the study was to evaluate whether anti-Müllerian hormone (AMH) is associated with fecundability among women with proven fecundity and a history of pregnancy loss. DESIGN: This was a prospective cohort study within a multicenter, block-randomized, double-blind, placebo-controlled clinical trial ( clinicaltrials.gov , number NCT00467363). SETTING: The study was conducted at four US medical centers (2006-2012). PARTICIPANTS: Participating women were aged 18-40 years, with a history of one to two pregnancy losses who were actively attempting pregnancy. MAIN OUTCOME MEASURES: Time to human chorionic gonadotropin detected and clinical pregnancy were assessed using Cox proportional hazard regression models to estimate fecundability odds ratios (fecundability odds ratios with 95% confidence interval [CI]) adjusted for age, race, body mass index, income, low-dose aspirin treatment, parity, number of previous losses, and time since most recent loss. Analyses examined by preconception AMH levels: low (3.5 ng/mL, n = 483). RESULTS: Of the 1202 women with baseline AMH levels, 82 women with low AMH (66.1%) achieved an human chorionic gonadotropin detected pregnancy, compared with 383 with normal AMH (65.2%) and 315 with high AMH level (65.2%). Low or high AMH levels relative to normal AMH (referent) were not associated with fecundability (low AMH: fecundability odds ratios 1.13, 95% CI 0.85-1.49; high AMH: FOR 1.04, 95% CI 0.87-1.24). CONCLUSIONS: Lower and higher AMH values were not associated with fecundability in unassisted conceptions in a cohort of fecund women with a history of one or two prior losses. Our data do not support routine AMH testing for preconception counseling in young, fecund women.

My notes (saved in your browser only)

MeSH descriptors

Anti-Mullerian Hormone Fertility Abortion, Spontaneous Abortion, Spontaneous Abortion, Spontaneous Adolescent Adult Anti-Mullerian Hormone Biomarkers Biomarkers Cohort Studies Double-Blind Method Female Fertility Humans Predictive Value of Tests Pregnancy Prospective Studies Socioeconomic Factors Treatment Outcome

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

Cited by (2)

References (41)

Cited by (2)

Source provenance

crossref
last seen: 2026-08-04T06:56:48.893218+00:00
europepmc
last seen: 2026-10-18T09:30:06.152893+00:00
pubmed
last seen: 2026-10-08T21:16:31.290043+00:00
unpaywall
last seen: 2026-10-24T06:30:43.844863+00:00